Table 1 Clinicopathologic characteristics of cohort.

From: Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners

Case

Age/sex

Site

Morphology

CD34

Desmin

Target RNA sequencing (Archer)

FISH

Follow-up (months)

1

4/F

Hip

Maturing

P

N

No fusion identified

NP

AWOD; 78

2

4/M

Neck

Maturing

P

Fo

CHCHD7-PLAG1

NP

NA

3

4/M

Leg

Maturing

P

Fo

CHCHD7-PLAG1

NP

AWOD; 28

4

6/M

Calf

Maturing

P

P

CHCHD7-PLAG1

NP

AWOD; 2

5

6/M

Arm

Maturing

P

N

HNRNPC-PLAG1a, CHCHD7-PLAG1

NP

AWOD; 25

6

6/F

Leg

Maturing

P

N

CHCHD7-PLAG1

NP

AWOD; 1

7

10/F

Neck

Maturing

P

P

COL3A1-PLAG1a, CHCHD7-PLAG1

NP

AWOD; 1

8

11/F

Pretibial

Maturing

P

N

No fusion identified

NP

NA

9

18/M

Palm

Maturing

P

N

No fusion identified

NP

AWOD; 107

10

19/M

Back

Maturing

P

N

No fusion identified

NP

NA

11

29/M

Neck

Maturing

P

N

No fusion identified

NP

NA

12

31/M

Palm

Maturing

NP

NP

No fusion identified

NP

AWOD; 54

13

31/M

Thigh

Maturing

P

P

No fusion identifiedb

N

NA

14

44/F

Thigh

Maturing

P

P

SRSF3-PLAG1

NP

AWOD; 1

15

4/F

Neck

Fibroblastic

P

Fo

PCMTD1-PLAG1

NP

AWOD; 17

16

7/M

Back

Fibroblastic

P

Fo

YWHAZ-PLAG1

NP

NA

17

10/M

Back

Fibroblastic

P

P

CTDSP2-PLAG1

N

NA

18

10/F

Arm

Fibroblastic

P

P

PPP2R2A-PLAG1b

N

AWOD; 5

19

16/M

Hand

Fibroblastic

P

P

No fusion identifiedb, c

P

NA

20

7/M

Ankle

Conventional

P

N

No fusion identified

NP

AWOD; 29

21

13/M

Arm

Conventional

P

Fo

CHCHD7-PLAG1b

N

NA

22

41/F

Foot

Conventional

P

N

No fusion identified

NP

NA

  1. F female, M male, FISH fluorescence in situ hybridization, NP not performed, Fo focal, AWOD alive without disease, NA not available.
  2. aDominant fusion.
  3. bWhole Transcriptome Sequencing (RNA-seq) also performed.
  4. cThe sample for RNA-seq has a low tumor content which may impact on the test sensitivity.